Answers are grounded in this paper and cite their sources.
Background: Hepatitis C (HCV) Infection is not uncommon in patients on maintenance hemodialysis (around 10% in our dialysis population). It is also known to increase morbidity and mortality in Renal Allograft Recipients more so in post-transplant period with various studies quoting mixed results.
No takes yet. Share an insight, caveat, or question.
Rohit et al. (2017) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: